What's the Next Big Splash for Dara Torres?
A Little R&R and Spreading the Word About AmLactin®
MAPLE GROVE, Minn., Sept. 20, 2012 /PRNewswire/ -- After three decades as a competitive swimmer, five-time Olympian, Dara Torres, emerged from her final lap at the 2012 Olympic Team Trials with her signature grace and style. Despite hanging up her Olympic cap, Torres shows no signs of slowing down and is looking eagerly toward this exciting new phase in her personal and professional life.
"From high school swim meets to swimming at the Olympic level, my time competing in the pool has largely shaped who I am. Now that this period of my life has come to a close, I am looking forward to sharing the experiences and knowledge I have picked up along the way," said Torres. "As the AmLactin® brand ambassador, I'm proud to continue to spread the word about this unique product as I transition into the next phase of my life. All the time I've spent in the water has taken quite a toll on my skin. The alpha hydroxy therapy in AmLactin® moisturizing lotion and cream penetrates dry skin and works as an exfoliant, making my skin look and feel amazing―it truly is 'serious care for softer skin.'"
Dara recommends twice daily application of a lactic acid rich moisturizer, like AmLactin® Moisturizing Body Lotion, to gently exfoliate by sloughing away dead skin cells and to intensely hydrate—minimizing time spent on skin care and maximizing time for everything else. AmLactin® moisturizers are specially formulated with alpha hydroxy therapy to gently encourage natural skin cell renewal through exfoliation, leaving skin soft and silky.
"Dara always stresses the importance of recovery time as a competitor, and that includes rehydrating her skin," said Glenn MacEachern, Director of Product Marketing, Upsher-Smith Laboratories, Inc. "She is much like the women we hear from every day who are seeking a serious skin care product for their rough, dry skin challenges. We are delighted that she is an AmLactin® believer."
About AmLactin® Alpha-Hydroxy Skin Care
AmLactin® moisturizers contain alpha hydroxy acids (AHAs), which are effective at exfoliating and hydrating the skin. AmLactin® formulas also contain emollients and humectants that help retain the skin's natural moisture and draw water to the skin so it looks and feels soft and smooth. The AmLactin® Alpha-Hydroxy Skin Care line includes AmLactin® Moisturizing Body Lotion, AmLactin® Ultra Hydrating Body Cream for severe dry skin (formerly AmLactin XL®), and AmLactin® Foot Cream.
AmLactin® Ultra Hydrating Body Cream is specially formulated for severe, persistently dry skin areas that need extra attention. It contains the advanced, patented ULTRAPLEX® formula that gently exfoliates and is clinically proven to intensely hydrate for long-lasting moisture. With rich humectants and creamy emollients, AmLactin® Ultra provides serious relief.
Sunburn Alert: This product contains an alpha-hydroxy acid (AHA) that may increase your skin's sensitivity to sunburn. Be sun smart: use sunscreen, wear protective clothing, and limit sun exposure while using this product and for a week afterward.
All AmLactin® products are available without a prescription at Costco, Walmart, Walgreens, CVS, Rite-Aid, the drugstore.com™ website, and other fine retailers nationwide. For more information, a store locator, and downloadable coupons, visit www.amlactin.com. For tips on managing dry skin associated with Keratosis Pilaris and "The Fundamentals of Fit Skin," visit www.littleredbumps.com, featuring the expertise of leading New York Cosmetic Dermatologist, Dr. Doris Day, along with five-time Olympian and mom, Dara Torres.
Upsher-Smith Laboratories, Inc. is a privately held, U.S.-based company devoted to improving health and advancing wellness since 1919. Upsher-Smith demonstrates its commitment to meeting the healthcare needs of its customers through developing, producing, and marketing consumer and prescription products. In addition to its strong heritage in generics, Upsher-Smith's branded businesses focus on women's health, dermatology, and CNS therapeutic areas. For additional information, visit http://www.upsher-smith.com.
SOURCE Upsher-Smith Laboratories, Inc.
More by this Source
Upsher-Smith Is Honored With Prestigious Industry Award For Leadership And Innovation
Jun 05, 2013, 12:00 ET
Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures
May 22, 2013, 09:30 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.